CompletedPhase 3NCT04281108
Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
Studying NON RARE IN EUROPE: Eosinophilic esophagitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ellodi Pharmaceuticals, LP
- Principal Investigator
- Evan Dellon, MD, MPHUNC Center for Eosphageal Diseases and Swallowing
- Intervention
- APT-1011(drug)
- Enrollment
- 143 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2022
Study locations (30)
- Pinnacle Research Group, LLC, Anniston, Alabama, United States
- Gut P.C., dba; Digestive Health Specialists of the Southeast, Dothan, Alabama, United States
- East View Medical Research, LLC, Mobile, Alabama, United States
- Del Sol Research Management, LLC, Tucson, Arizona, United States
- Preferred Research Partners Inc., Little Rock, Arkansas, United States
- Arkansas Gastroenterology, North Little Rock, Arkansas, United States
- Camarillo Endoscopy Center, Camarillo, California, United States
- Hope Clinical Research, Canoga Park, California, United States
- Facey Medical Foundation, Mission Hills, California, United States
- United Medical Doctors, Murrieta, California, United States
- Medical Associates Research Group, San Diego, California, United States
- Asthma and Allergy Associates, PC, Colorado Springs, Colorado, United States
- Peak Gastroenterology Associates, Colorado Springs, Colorado, United States
- Western States Clinical Research Inc., Wheat Ridge, Colorado, United States
- Western Connecticut Medical Group - Gastroenterology, Danbury, Connecticut, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04281108 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Eosinophilic esophagitis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONEARLY PHASE1NCT07358234Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.Mayo Clinic
- RECRUITINGNANCT07234825Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic EsophagitisKate Farms Inc
- RECRUITINGPHASE3NCT07112378A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic EsophagitisRegeneron Pharmaceuticals
- RECRUITINGNCT07156357Surface EMG Testing on Swallowing in EoE PatientsMayo Clinic
- RECRUITINGNCT06972147Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic EsophagitisUniversity Hospital, Angers
- RECRUITINGNCT07012928Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II InflammationAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- RECRUITINGPHASE2NCT05485155Zemaira Eosinophilic Esophagitis Pilot StudyChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06756581Tolerability of Baked Dairy Protein in Eosinophilic Esophagitis Patients With Cow Milk Protein TriggerShaare Zedek Medical Center
See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis →